PanCan模型与Lung-RADS评估筛查检出实性肺结节癌症概率的比较
本研究基于美国国家肺癌筛查试验低剂量CT臂数据,对6956例筛查检出实性结节分别计算PanCan风险和Lung-RADS评分。
要点
- PanCan与Lung-RADS对筛查检出实性结节的整体癌症预测准确性相似。
- 两模型在高危/低危二分时存在显著不一致,亚组分布有差异。
- PanCan风险3%~5%但无对应Lung-RADS类别的结节可能导致不必要侵入性操作。
核心结论
- PanCan模型与Lung-RADS对筛查检出实性肺结节的癌症评估整体准确性相似,但亚组间存在不一致证据。
- 存在PanCan风险≥3%~5%但无对应Lung-RADS类别的结节,可能导致不必要的侵入性操作。
研究设计与样本
- 分析美国国家肺癌筛查试验低剂量CT臂中任何筛查轮次新发现的实性结节数据。
- 为结节分配PanCan风险和Lung-RADS评分,比较预期癌症患病率对应的类别。
- 采用逻辑回归评估准确性,并分析模型间一致性。
- 共6956例参与者具有可计算的PanCan风险和Lung-RADS评分。
主要发现
- PanCan在癌症概率<1%、1%~2%、5%~15%、>15%的准确性与对应Lung-RADS类别2、3、4A、4B相似。
- 风险缺口结节(n=543)分布于Lung-RADS类别2至4,其中41例(8%)接受侵入性操作,23例(4%)为良性实性结节的不必要操作。
关键数值与推荐
- PanCan高危定义为癌症概率≥5%。
- 风险缺口结节定义为PanCan概率3%~5%且无对应Lung-RADS类别。
- PanCan概率<1%、1%~2%、5%~15%、>15%分别对应Lung-RADS类别2、3、4A、4B。
临床怎么用
- 临床可参考PanCan与Lung-RADS对筛查检出实性结节进行癌症风险评估。
- 对PanCan风险3%~5%但Lung-RADS分类不明确的结节,需谨慎决定是否侵入性操作。
- 注意两模型在高危/低危二分时的不一致,避免仅凭单一模型决策。
局限性
- 研究基于美国国家肺癌筛查试验低剂量CT臂数据,外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Pan-Canadian Early Detection of Lung Cancer (PanCan) risk model and the Lung CT Screening Reporting & Data System (Lung-RADS) estimate cancer probability for screening-detected nodules. The accuracy and agreement of these models require further study. RESEARCH QUESTION: What is the performance of the PanCan model and Lung-RADS to estimate the probability of cancer in screening-detected solid nodules? STUDY DESIGN AND METHODS: We analyzed data for newly identified, solid nodules detected on any screening round in the low-dose CT arm of the National Lung Screening Trial to assign a PanCan risk and Lung-RADS score. We compared PanCan risk with the corresponding Lung-RADS category according to the expected prevalence of cancer and examined accuracy using logistic regression and between-test agreement. We also analyzed baseline screen-detected nodules only, high (defined as ≥ 5% probability of cancer) vs low-risk nodules, "risk-gap" nodules with a 3% to 5% PanCan probability and no equivalent Lung-RADS category, and procedure use by model. RESULTS: Participants with solid nodules (6,956) had a calculable PanCan risk and Lung-RADS score. PanCan accuracy by cancer probabilities < 1%, 1% to 2%, 5% to 15%, and > 15% was similar to corresponding Lung-RADS categories 2, 3, 4A, and 4B for any solid nodule (area under the curve, 0.84 vs 0.84; P = .95) and for nodules identified at baseline (area under the curve, 0.85 vs 0.84; P = .17). When dichotomized by high/low risk, PanCan and Lung-RADS were discordant (P < .001). Participants with risk-gap nodules (n = 543) were distributed across Lung-RADS categories 2 through 4; 41 (8%) had invasive procedures with 23 (4%) having unnecessary invasive procedure use for solid, benign nodules. INTERPRETATION: PanCan and Lung-RADS had similar overall accuracy for assessing cancer in screening-detected, solid lung nodules with evidence of discordance by subgroup. The existence of Lung-RADS category 4 nodules with a ≥ 3% to 5% PanCan risk may result in unnecessary procedures.
引用
- Sundaram V, Gould MK, Nair VS, et al. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules. Chest. 2020. PMID: 33393476. doi:10.1016/j.chest.2020.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。